Dietary downregulation of mutant p53 levels via glucose restriction

References

• Freed-Pastor WA, Prives C. Mutant p53: one name, many proteins. Genes Dev 2012; 26:1268 - 86; http://dx.doi.org/10.1101/gad.190678.112; PMID: 22713868
   PubMed Web of Science ®Google Scholar
• Prives C, White E. Does control of mutant p53 by Mdm2 complicate cancer therapy?. Genes Dev 2008; 22:1259 - 64; http://dx.doi.org/10.1101/gad.1680508; PMID: 18483214
   PubMed Web of Science ®Google Scholar
• Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM, et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 2004; 119:861 - 72; http://dx.doi.org/10.1016/j.cell.2004.11.006; PMID: 15607981
   PubMed Web of Science ®Google Scholar
• Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 2004; 119:847 - 60; http://dx.doi.org/10.1016/j.cell.2004.11.004; PMID: 15607980
   PubMed Web of Science ®Google Scholar
• Terzian T, Suh YA, Iwakuma T, Post SM, Neumann M, Lang GA, et al. The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss. Genes Dev 2008; 22:1337 - 44; http://dx.doi.org/10.1101/gad.1662908; PMID: 18483220
   PubMed Web of Science ®Google Scholar
• Brosh R, Rotter V. When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 2009; 9:701 - 13; PMID: 19693097
   PubMed Web of Science ®Google Scholar
• Kruse JP, Gu W. Modes of p53 regulation. Cell 2009; 137:609 - 22; http://dx.doi.org/10.1016/j.cell.2009.04.050; PMID: 19450511
   PubMed Web of Science ®Google Scholar
• Knights CD, Catania J, Di Giovanni S, Muratoglu S, Perez R, Swartzbeck A, et al. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol 2006; 173:533 - 44; http://dx.doi.org/10.1083/jcb.200512059; PMID: 16717128
   PubMed Web of Science ®Google Scholar
• Singh R, Cuervo AM. Autophagy in the cellular energetic balance. Cell Metab 2011; 13:495 - 504; http://dx.doi.org/10.1016/j.cmet.2011.04.004; PMID: 21531332
   PubMed Web of Science ®Google Scholar
• Kimmelman AC. The dynamic nature of autophagy in cancer. Genes Dev 2011; 25:1999 - 2010; http://dx.doi.org/10.1101/gad.17558811; PMID: 21979913
   PubMed Web of Science ®Google Scholar
• Liu EY, Ryan KM. Autophagy and cancer--issues we need to digest. J Cell Sci 2012; 125:2349 - 58; http://dx.doi.org/10.1242/jcs.093708; PMID: 22641689
   PubMed Web of Science ®Google Scholar
• Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402:672 - 6; http://dx.doi.org/10.1038/45257; PMID: 10604474
   PubMed Web of Science ®Google Scholar
• Turcotte S, Chan DA, Sutphin PD, Hay MP, Denny WA, Giaccia AJ. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 2008; 14:90 - 102; http://dx.doi.org/10.1016/j.ccr.2008.06.004; PMID: 18598947
   PubMed Web of Science ®Google Scholar
• Scherz-Shouval R, Weidberg H, Gonen C, Wilder S, Elazar Z, Oren M. p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proc Natl Acad Sci USA 2010; 107:18511 - 6; http://dx.doi.org/10.1073/pnas.1006124107; PMID: 20937856
   PubMed Web of Science ®Google Scholar
• Crighton D, Wilkinson S, O’Prey J, Syed N, Smith P, Harrison PR, et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006; 126:121 - 34; http://dx.doi.org/10.1016/j.cell.2006.05.034; PMID: 16839881
   PubMed Web of Science ®Google Scholar
• Tasdemir E, Chiara Maiuri M, Morselli E, Criollo A, D’Amelio M, Djavaheri-Mergny M, et al. A dual role of p53 in the control of autophagy. Autophagy 2008; 4:810 - 4; PMID: 18604159
   PubMed Web of Science ®Google Scholar
• Morselli E, Tasdemir E, Maiuri MC, Galluzzi L, Kepp O, Criollo A, et al. Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 2008; 7:3056 - 61; http://dx.doi.org/10.4161/cc.7.19.6751; PMID: 18818522
   PubMed Web of Science ®Google Scholar
• Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 2005; 18:283 - 93; http://dx.doi.org/10.1016/j.molcel.2005.03.027; PMID: 15866171
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009; 324:1076 - 80; http://dx.doi.org/10.1126/science.1164097; PMID: 19461003
   PubMed Web of Science ®Google Scholar
• Moll UM, Petrenko O. The MDM2-p53 interaction. Mol Cancer Res 2003; 1:1001 - 8; PMID: 14707283
   PubMed Web of Science ®Google Scholar
• White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 2012; 12:401 - 10; http://dx.doi.org/10.1038/nrc3262; PMID: 22534666
   PubMed Web of Science ®Google Scholar
• Yu L, Wan F, Dutta S, Welsh S, Liu Z, Freundt E, et al. Autophagic programmed cell death by selective catalase degradation. Proc Natl Acad Sci USA 2006; 103:4952 - 7; http://dx.doi.org/10.1073/pnas.0511288103; PMID: 16547133
   PubMed Web of Science ®Google Scholar
• Freed-Pastor WA, Mizuno H, Zhao X, Langerød A, Moon SH, Rodriguez-Barrueco R, et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 2012; 148:244 - 58; http://dx.doi.org/10.1016/j.cell.2011.12.017; PMID: 22265415
   PubMed Web of Science ®Google Scholar
• Peng T, Golub TR, Sabatini DM. The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol Cell Biol 2002; 22:5575 - 84; http://dx.doi.org/10.1128/MCB.22.15.5575-5584.2002; PMID: 12101249
   PubMed Web of Science ®Google Scholar
• Lee C, Longo VD. Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients. Oncogene 2011; 30:3305 - 16; http://dx.doi.org/10.1038/onc.2011.91; PMID: 21516129
   PubMed Web of Science ®Google Scholar
• Donehower LA, Lozano G. 20 years studying p53 functions in genetically engineered mice. Nat Rev Cancer 2009; 9:831 - 41; http://dx.doi.org/10.1038/nrc2731; PMID: 19776746
   PubMed Web of Science ®Google Scholar
• Harvey M, Vogel H, Morris D, Bradley A, Bernstein A, Donehower LA. A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nat Genet 1995; 9:305 - 11; http://dx.doi.org/10.1038/ng0395-305; PMID: 7773294
   PubMed Web of Science ®Google Scholar
• Tzeng YJ, Zimmermann C, Guhl E, Berg B, Avantaggiati ML, Graessmann A. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors. Oncogene 1998; 16:2103 - 14; http://dx.doi.org/10.1038/sj.onc.1201733; PMID: 9572491
   PubMed Web of Science ®Google Scholar
• Maddocks OD, Vousden KH. Metabolic regulation by p53. J Mol Med (Berl) 2011; 89:237 - 45; http://dx.doi.org/10.1007/s00109-011-0735-5; PMID: 21340684
   PubMed Web of Science ®Google Scholar
• Vousden KH, Ryan KM. p53 and metabolism. Nat Rev Cancer 2009; 9:691 - 700; http://dx.doi.org/10.1038/nrc2715; PMID: 19759539
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ. Potential therapeutic applications of autophagy. Nat Rev Drug Discov 2007; 6:304 - 12; http://dx.doi.org/10.1038/nrd2272; PMID: 17396135
   PubMed Web of Science ®Google Scholar
• Gusdon AM, Chu CT. To eat or not to eat: neuronal metabolism, mitophagy, and Parkinson’s disease. Antioxid Redox Signal 2011; 14:1979 - 87; http://dx.doi.org/10.1089/ars.2010.3763; PMID: 21126205
   PubMed Web of Science ®Google Scholar
• Catalina-Rodriguez O, Kolukula VK, Tomita Y, Preet A, Palmieri F, Wellstein A, et al. The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis. Oncotarget 2012; In press PMID: 23100451
   PubMed Web of Science ®Google Scholar
• Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, et al. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 2012; 149:1269 - 83; http://dx.doi.org/10.1016/j.cell.2012.04.026; PMID: 22682249
   PubMed Web of Science ®Google Scholar
• Perez RE, Knights CD, Sahu G, Catania J, Kolukula VK, Stoler D, et al. Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway. J Cell Physiol 2010; 225:394 - 405; http://dx.doi.org/10.1002/jcp.22285; PMID: 20589832
   PubMed Web of Science ®Google Scholar
• Ding WX, Yin XM. Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy 2008; 4:141 - 50; PMID: 17986870
   PubMed Web of Science ®Google Scholar
• Dey A, Lane DP, Verma CS. Modulating the p53 pathway. Semin Cancer Biol 2010; 20:3 - 9; http://dx.doi.org/10.1016/j.semcancer.2010.02.004; PMID: 20193765
   PubMed Web of Science ®Google Scholar
• Stanga S, Lanni C, Govoni S, Uberti D, D’Orazi G, Racchi M. Unfolded p53 in the pathogenesis of Alzheimer’s disease: is HIPK2 the link?. Aging (Albany NY) 2010; 2:545 - 54; PMID: 20876941
   PubMedGoogle Scholar
• Thomas M, Dadgar N, Aphale A, Harrell JM, Kunkel R, Pratt WB, et al. Androgen receptor acetylation site mutations cause trafficking defects, misfolding, and aggregation similar to expanded glutamine tracts. J Biol Chem 2004; 279:8389 - 95; http://dx.doi.org/10.1074/jbc.M311761200; PMID: 14670946
   PubMed Web of Science ®Google Scholar